Bavarian Nordic, the Danish company, which is the only holder of a vaccine against monkey pox is undervalued, according to Wolfteam Ltd.'s projections and estimates.
Monkey pox might not spread as much and as fast or be as deadly as the coronavirus, but monkey pox could well spread. Bavarian Nordic holds a monopoly on cure from monkey pox with its vaccine.
Bavarian Nordic intrinsic worth could reach 30 billion USD if monkey pox spread to a mid level. Bavarian Nordic's current market capitalization is 3.2 billion USD.
No comments:
Post a Comment